U.S. Software Stock News

Nu Holdings (NYSE:NU) is back in the spotlight after fresh data highlighted how its tech driven banking model in Latin America is still translating into rising profits and better unit economics, sharpening focus on what the stock is truly worth. See our latest analysis for Nu Holdings. That optimism has not gone unnoticed in the market, with Nu’s share price up a strong year to date on the back of consistent earnings beats and expanding margins. At the same time, recent pullbacks suggest some...

In recent days, Cinemark Holdings reported a weak third quarter, with net income and revenue falling, just as Netflix’s planned acquisition of Warner Bros Discovery raised fresh questions about the future of theatrical release windows for major films. Together, the earnings disappointment and uncertainty around how a combined Netflix–Warner Bros Discovery might prioritize streaming versus theaters are forcing investors to reassess how durable Cinemark’s traditional cinema model may be. Next,...

QCR Holdings (QCRH) just delivered a standout Q3, with revenue and earnings comfortably ahead of Wall Street estimates. The stock has climbed about 20% since, signaling renewed investor conviction in this regional bank. See our latest analysis for QCR Holdings. That upbeat Q3 has capped a strong run, with a 1 month share price return of 13.44% and year to date share price gains contributing to a 3 year total shareholder return of 78.21%, suggesting momentum is building rather than fading. If...

Reinsurance Group of America (RGA) has quietly slipped about 2% over the past week and roughly 11% over the past year, even as its revenue and earnings continue to grow at a solid clip. See our latest analysis for Reinsurance Group of America. At around $188.64, the recent slide in RGA’s share price looks more like a pause than a breakdown. Short term share price pressure contrasts sharply with its robust multi year total shareholder returns, suggesting momentum is cooling but not broken. If...

Molson Coors Beverage recently reported that Madrí Excepcional has surpassed £1.00 billion in annual sales, becoming the UK’s second-largest world lager brand just five years after its launch, while its alcohol-free Madrí Excepcional 0.0% generated more than £1.50 million in revenue in its first six months. This rapid rise of Madrí Excepcional highlights how Molson Coors’ premium and low- or no-alcohol offerings can broaden its portfolio mix and support higher-margin, international...

Stronger earnings, softer reaction IHS Holding (NYSE:IHS) just posted third quarter 2025 earnings that blew past forecasts and raised its full year revenue outlook, yet the stock slipped in pre market trading as investors dug into the details. The company also laid out plans to expand further in Brazil and bring more AI into its operations, while signaling it may consider dividends or buybacks in the future. These moves could reshape how investors think about its growth and capital return...

In its latest update, The Greenbrier Companies reported fiscal Q4 orders for 2,400 railcars worth over US$300 million, delivered 4,900 units, and ended August 2025 with a backlog of 16,600 railcars valued at nearly US$2.20 billion. The company’s lease fleet expanded about 10% in fiscal 2025 with 98% utilization and it paid its 46th consecutive quarterly dividend on December 3, 2025, underscoring sustained demand for its equipment and services. We’ll now examine how this strong railcar...

Corning (GLW) is back on investors radar after its optical communications business again took center stage in the latest earnings update, with AI driven data center demand powering a meaningful jump in sales and profit contribution. See our latest analysis for Corning. That backdrop helps explain why Corning’s share price has climbed to about $88, with a powerful year to date share price return of roughly 89 percent and a three year total shareholder return above 180 percent, signaling...

If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Typically, we'll...

Barclays has taken a more constructive view on Compass, upgrading the stock after highlighting expected benefits from its HOUS acquisition, an improved pitch to agents, and potential upside as existing home sales gradually recover. See our latest analysis for Compass. That backdrop helps explain why momentum in Compass shares has been building, with a 21.87% 1 month share price return, a 79.66% year to date share price return, and a striking 294.70% 3 year total shareholder return, even...

PPG Industries (PPG) has been drifting lower this year, even as its latest annual results showed steady revenue and earnings growth. That disconnect is what has investors revisiting the coatings giant’s valuation today. See our latest analysis for PPG Industries. Despite a recent 1 month share price return of 4.28 percent, PPG is still down 13.04 percent year to date and its 1 year total shareholder return of negative 18.79 percent underlines that momentum has been fading as investors...

Liberty Energy (LBRT) is back in the spotlight after UBS kicked off coverage with a bullish stance, adding its voice to upbeat views from Citigroup and RBC Capital and sharpening investor focus on the stock. See our latest analysis for Liberty Energy. Those bullish calls land as Liberty Energy trades around $19.40, with a strong 90 day share price return of 93.61 percent contrasting with a softer year to date share price return and a still solid 1 year total shareholder return of 14.10...

Cogent Biosciences (COGT) just cleared an important de risking step by reporting positive APEX Part 2 data for bezuclastinib in advanced systemic mastocytosis, which now underpins its planned FDA filing in 2026. See our latest analysis for Cogent Biosciences. Those APEX and SUMMIT readouts have clearly shifted how investors see Cogent’s risk profile, with a roughly 172 percent 1 month share price return and a 417 percent year to date share price return suggesting momentum is firmly building...

Beacon Pointe Advisors LLC recently disclosed a new position in Dorchester Minerals, L.P. worth about US$1.14 million, coinciding with the partnership’s decision to lift its quarterly distribution to a yield of around 12.0% and fresh insider share purchases by the CEO and a director. This combination of higher income payouts, institutional capital inflows, and insider buying has drawn attention to how Dorchester Minerals’ management and professional investors view the partnership’s prospects...

In early December 2025, SiTime Corporation launched its Endura ENDR-TTT Super-TCXO, an ultra-stable, low-power oscillator engineered to extend GNSS holdover, improve spoofing resistance, and withstand extreme temperatures and shock for aerospace, defense, and industrial timing applications. By offering much longer holdover, far better PNT accuracy, and sharply reduced g-sensitivity versus quartz, the new oscillator aims to address mission-critical timing needs where GNSS signals are...

Recent Stock Performance and Context Avantor (AVTR) has been grinding lower, with the stock down about 2% on the day and roughly 17% over the past 3 months, extending a much longer slide. See our latest analysis for Avantor. The latest pullback leaves Avantor’s share price at $10.71, and that weak near term share price return sits on top of a much steeper year to date share price decline. This suggests momentum is still fading as investors reassess growth versus execution risk. If you are...

Alexander & Baldwin (ALEX) has quietly slid about 19% over the past 3 months, putting the Hawaii focused REIT back on value investors’ radar as they weigh its income profile against relatively softer growth. See our latest analysis for Alexander & Baldwin. That recent slide sits against a longer history where the 1 year total shareholder return is negative, even though the 5 year total shareholder return is still positive. This suggests momentum has cooled as investors reassess growth and...

Boeing (BA) shares have been grinding higher recently, and the move has investors asking whether this is just a relief rally or the start of a more durable recovery in the aerospace cycle. See our latest analysis for Boeing. At a latest share price of $206.27, Boeing’s recent 7 day share price return of 10.62 percent and 1 year total shareholder return of 31.35 percent suggest momentum is rebuilding after a softer 90 day share price return of negative 10.13 percent. If Boeing’s rebound has...

U.S. Physical Therapy (USPH) has quietly moved higher over the past week, and that modest rebound stands out against a tougher past 3 months, inviting a closer look at what the market is pricing in. See our latest analysis for U.S. Physical Therapy. That recent 7 day share price return of 2.6% only slightly dents a much weaker year to date. With the 1 year total shareholder return down nearly 20%, momentum still looks more like a reset than a full recovery. If this kind of healthcare name is...

ACV Auctions (ACVA) has been in focus after rolling out AI powered inspection tools and accelerating its commercial expansion, a combination that could reshape how dealers source, evaluate, and move used vehicles on its marketplace. See our latest analysis for ACV Auctions. Despite the buzz around its AI inspections and yard expansion, ACV Auctions’ 1 month share price return of 50.37% comes after a tough stretch, with its 1 year total shareholder return still down 63.34%. This suggests that...

In recent days, Northslope, Teton Ridge, and other partners have deepened their work with Palantir, while the company unveiled its Chain Reaction operating system to tackle AI’s power and compute bottlenecks across energy, grid, and data-center infrastructure, alongside expanding real-time AI collaborations with NVIDIA. These moves highlight how Palantir is pushing its AI platforms into both niche arenas like rodeo sports and mission-critical infrastructure, widening the range of problems...

On December 8, 2025, Structure Therapeutics reported positive topline Phase 2 data for its oral GLP-1 agonist aleniglipron in obesity, showing clinically meaningful, statistically significant weight loss and a safety profile aligned with the drug class across multiple ACCESS studies and an open-label extension. A key insight is that aleniglipron’s once-daily oral, nonpeptide design and lower 2.5 mg starting dose strategy may directly address tolerability and accessibility challenges seen...

Enovix recently reported an 85% year-over-year revenue increase for its fiscal 2025 third quarter, largely powered by growing demand from defense customers following heightened global military spending. This surge in defense-driven sales comes as the company’s valuation has pulled back toward multi-year lows, sharpening investor focus on how its technology fits into expanding security budgets. We’ll now examine how this defense-fueled revenue momentum could influence Enovix’s existing...

In recent years, Ally Financial has faced a 3.2% annual sales decline and falling earnings per share, while its tier one capital ratio stands at 9.7%, raising questions about balance sheet resilience as of today, 9 December 2025. These pressures suggest investors are increasingly focused on whether Ally’s current capital and earnings profile can withstand a more challenging credit and funding backdrop. We’ll now examine how concerns over Ally’s relatively low tier one capital ratio may...